- Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes Endpoints News
- ‘Godzilla’ of weight-loss drugs could provide other important health benefits The Guardian
- Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial CNBC
- EASD26: Lilly breaks down retatrutide dosage data from TRIUMPH-2 FirstWord
- Lilly Drug Combo Spurs Record Weight Loss in Diabetes Study Bloomberg.com